These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5899873)

  • 1. [On the detection of sulfonamide crystals in the kidney].
    Theiss E; Studer A; Waldmann H
    Arzneimittelforschung; 1965 Nov; 15(11):1352-5. PubMed ID: 5899873
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental stone formation and experimental pyelonephritis caused by persorption.
    Brosig W; Löhe E; Riedel B
    Invest Urol; 1972 Sep; 10(2):151-3. PubMed ID: 5077604
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal calcification in suckling rats after high doses of calcitriol (1,25-dihydroxycholecalciferol).
    Dostal LA; Toverud SU; Peach R
    Arch Pathol Lab Med; 1984 May; 108(5):410-5. PubMed ID: 6546866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity.
    Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of sulfonamide therapy on formation of calculi in the kidney pelvis].
    DOTSENKO NS
    Pediatriia; 1955; 1():33-8. PubMed ID: 14384419
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of eight sulfonamides in bovine kidney by liquid chromatography/tandem mass spectrometry with on-line extraction and sample clean-up.
    Van Eeckhout N; Perez JC; Van Peteghem C
    Rapid Commun Mass Spectrom; 2000; 14(24):2331-8. PubMed ID: 11114046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of sulfonamide residues in milk].
    Fechner G; Töpfer H; Pannwitz E
    Monatsh Veterinarmed; 1972 Aug; 27(16):613-5. PubMed ID: 4678258
    [No Abstract]   [Full Text] [Related]  

  • 9. Flow cytometric immunoassay for sulfonamides in raw milk.
    de Keizer W; Bienenmann-Ploum ME; Bergwerff AA; Haasnoot W
    Anal Chim Acta; 2008 Jul; 620(1-2):142-9. PubMed ID: 18558135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robustness of the extraction step when parallel factor analysis (PARAFAC) is used to quantify sulfonamides in kidney by high performance liquid chromatography-diode array detection (HPLC-DAD).
    García I; Sarabia L; Ortiz MC; Aldama JM
    Analyst; 2004 Aug; 129(8):766-71. PubMed ID: 15284923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological and immunocytochemical changes in chronic calcium oxalate nephrolithiasis in the rat.
    de Water R; Boevé ER; van Miert PP; Vermaire CP; van Run PR; Cao LC; de Bruijn WC; Schröder FH
    Scanning Microsc; 1996; 10(2):577-87; discussion 587-90. PubMed ID: 9813633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol.
    Huang HS; Ma MC; Chen J; Chen CF
    J Urol; 2002 Jun; 167(6):2584-93. PubMed ID: 11992092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible acute renal failure due to sulfonamide-induced lithiasis in an AIDS patient.
    Fariña LA; Palou Redorta J; Chechile Toniolo G
    Arch Esp Urol; 1995 May; 48(4):418-9. PubMed ID: 7598556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physico-chemical and crystallographic data on renal calculi in mercuric chloride nephropathy in a mammal, the rabbit].
    Martoja R; Mélières F; Raynaud C; Truchet M
    C R Seances Acad Sci III; 1981 Apr; 292(14):857-62. PubMed ID: 6453667
    [No Abstract]   [Full Text] [Related]  

  • 15. Review on enzyme-linked immunosorbent assays for sulfonamide residues in edible animal products.
    Zhang H; Wang S
    J Immunol Methods; 2009 Oct; 350(1-2):1-13. PubMed ID: 19643106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic role of phycocyanin: a study of oxalate mediated renal cell injury.
    Farooq SM; Asokan D; Kalaiselvi P; Sakthivel R; Varalakshmi P
    Chem Biol Interact; 2004 Aug; 149(1):1-7. PubMed ID: 15294440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad-specificity immunoassays for sulfonamide detection: immunochemical strategy for generic antibodies and competitors.
    Franek M; Diblikova I; Cernoch I; Vass M; Hruska K
    Anal Chem; 2006 Mar; 78(5):1559-67. PubMed ID: 16503608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of flow-through and dip-stick immunoassays for screening of sulfonamide residues.
    Zhang H; Zhang Y; Wang S
    J Immunol Methods; 2008 Aug; 337(1):1-6. PubMed ID: 18589437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.